Skip to main content
PILL logo
PILL
(NYSEARCA)
Direxion Daily Pharmaceutical & Medical Bull 3X ETF
$20.99-- (--)
Loading... - Market loading

PILL ETF: Direxion Daily Pharmaceutical & Medical Bull 3X ETF - Price, Holdings & Analysis

Direxion Daily Pharmaceutical & Medical Bull 3X ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$20.83 - $22.25
52-Week High$24.15
52-Week Low$7.06
Open$22.10
Volume87.11K
Average Volume (3M)53.80K
Assets (AUM)21.48M
Expense Ratio0.98%
Total Holdings75
Inception DateNov 15, 2017
1 Day Change-6.19%
1 Month Change7.28%
6 Month Change63.77%
YTD Change77.98%
1 Year Change162.94%
52-Week Change164.94%
5 Year Change11.21%
50-Day MA$19.60
200-Day MA$13.78
RSI49.75
Stochastic %K23.15
Stochastic %D49.24
Annual Dividend$0.11
Dividend Yield0.53%
Last Dividend Ex-DateSep 30, 2026
Dividend Growth YoY30.95%

Frequently Asked Questions About Direxion Daily Pharmaceutical & Medical Bull 3X ETF

What is the current price of PILL?

The latest PILL price is $20.93. The 52-week range is $7.06–$24.15. PILL has returned 164.9% over the past 52 weeks.

What is the expense ratio for PILL?

PILL's annual expense ratio is 0.98%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does PILL pay dividends?

Yes, PILL pays a 0.53% dividend yield. The last ex-dividend date was 2026-09-30. View full dividend history in the Dividends section.

What are the top holdings of PILL?

PILL's largest holdings are Corcept Therapeutics Incorporated (2.8%), Crinetics Pharmaceuticals, Inc. (2.7%), Organon & Co. (2.4%) (combined weight: 7.9%). The fund holds 75 total positions. View the complete portfolio breakdown in the Holdings section.

How does PILL compare to similar ETFs?

Compare PILL (0.98% expense ratio, $21M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.